← Back to Search

Blood Flow Restriction Training for Torn Meniscus

N/A
Recruiting
Led By Sachin Allahabadi, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 9 (evaluated weekly at physical therapy visits from 0-12 weeks)
Awards & highlights

Study Summary

This trial will compare post-operative outcomes of patients undergoing blood flow restriction training as part of their rehabilitation to those undergoing standard rehabilitation after meniscus surgery.

Who is the study for?
This trial is for individuals who are having arthroscopic surgery to repair a torn meniscus. It's not suitable for those with diabetes, vascular diseases, or infections in the affected limb, nor for patients receiving additional ligament surgeries.Check my eligibility
What is being tested?
The study compares two post-surgery rehab methods after meniscus repair: one group will receive blood flow restriction training using a tourniquet system and the other will follow standard rehabilitation practices.See study design
What are the potential side effects?
Blood flow restriction may cause discomfort, temporary numbness, or bruising where the tourniquet is applied. Standard rehabilitation typically has minimal side effects but can include muscle soreness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 6 (evaluated weekly at physical therapy visits from 0-12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6 (evaluated weekly at physical therapy visits from 0-12 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Knee extension torque at Week 1
Knee extension torque at Week 10
Knee extension torque at Week 11
+21 more
Secondary outcome measures
3-hop test at Week 12
3-hop test at Week 24
International Knee Documentation Committee (IKDC) Score at Week 12
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blood flow restrictionExperimental Treatment2 Interventions
The blood flow restriction arm will include the use of the pneumatic tourniquet applied to the operative lower extremity throughout post-operative rehabilitation sessions. The tourniquet pressure will be titrated to 80% of the measured extremity arterial limb occlusion pressure with the participant lying supine.
Group II: Standard rehabilitationPlacebo Group1 Intervention
The standard rehabilitation arm will undergo the same rehabilitation protocol as the experimental arm. A tourniquet will still be applied, but will only be inflated to 20 mmHg, a pressure that will not occlude blood flow.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,485 Total Patients Enrolled
Sachin Allahabadi, MDPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Standard rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT04436523 — N/A
Torn Meniscus Research Study Groups: Standard rehabilitation, Blood flow restriction
Torn Meniscus Clinical Trial 2023: Standard rehabilitation Highlights & Side Effects. Trial Name: NCT04436523 — N/A
Standard rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04436523 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research involve participants who are above 20 years old?

"This trial is meant for patients aged 18-60, with 48 other trials being designed for patients below the age of 18, and 156 trials for patients 65 and older."

Answered by AI

How many study participants are you working with in total?

"The listing on clinicaltrials.gov verifies that this trial is currently looking for participants. The study was first advertised on October 20th, 2020, with the most recent update on November 8th, 2021. They are hoping to enroll 70 patients at a single site."

Answered by AI

Who would this research project be most appropriate for?

"Currently, the trial is looking for 70 individuals that are between 18-60 years old that have muscular atrophy. The most vital requirement for candidates is that they have undergone arthroscopic meniscus repair."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Blood Flow Restriction After Meniscus Repair
2020. "Blood Flow Restriction After Meniscus Repair". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04436523.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top